Search Results 451-460 of 11026 for total t4
* Pathologic stages T1c-T4, N0-Nx-N1, M0-1 as ... T4, prostate specific antigen (PSA) ≥ 20 * ... * Patients must complete all required pre-entry tests * ...
... total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...
... total symptom score from baseline to Week 24 as measured by the Myeloproliferative Neoplasm Symptom Assessment Form 2.0. Participation eligibility.
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...
... overall, 7% of patients develop CHF (median follow-up 8.5 years). A Prospective Ocular Tumor Study. Rochester, Minn. The purpose of this study is to use ...
At screening, complete surgical resection of the ... T4 tumors will only be eligible if they are defined as T4 ... Nodal status should be investigated with whole ...
This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing neurocognitive ...
Cancer treatments, including surgery, radiation, chemotherapy, targeted therapy and immunotherapy, are often combined to cure or control various cancers.
Subsequently, correlate these findings to assess overall surgical and clinical outcomes. Understanding the Relationship Between Benign Breast Tissue, Benign ...
Once this is complete treatment will be directed based on the genomic signature of patients individual tumor. Participation eligibility. Participant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.